Utilitat clínica de la condroïtina sulfat
Clinical utility of condroitin sulfate
Read
7840
Timeswas read the article
3001
Total PDF
4839
Total HTML
Article information
ISSN: X8866581Original language: Català
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 9 | 2 | 11 |
| 2025 5 | 89 | 25 | 114 |
| 2025 4 | 101 | 27 | 128 |
| 2025 3 | 89 | 30 | 119 |
| 2025 2 | 89 | 35 | 124 |
| 2025 1 | 59 | 30 | 89 |
| 2024 12 | 72 | 38 | 110 |
| 2024 11 | 58 | 39 | 97 |
| 2024 10 | 55 | 27 | 82 |
| 2024 9 | 55 | 22 | 77 |
| 2024 8 | 69 | 27 | 96 |
| 2024 7 | 53 | 35 | 88 |
| 2024 6 | 44 | 23 | 67 |
| 2024 5 | 65 | 32 | 97 |
| 2024 4 | 45 | 32 | 77 |
| 2024 3 | 51 | 30 | 81 |
| 2024 2 | 35 | 19 | 54 |
| 2024 1 | 41 | 24 | 65 |
| 2023 12 | 40 | 33 | 73 |
| 2023 11 | 48 | 42 | 90 |
| 2023 10 | 52 | 45 | 97 |
| 2023 9 | 43 | 46 | 89 |
| 2023 8 | 39 | 9 | 48 |
| 2023 7 | 60 | 15 | 75 |
| 2023 6 | 90 | 27 | 117 |
| 2023 5 | 79 | 19 | 98 |
| 2023 4 | 33 | 22 | 55 |
| 2023 3 | 56 | 29 | 85 |
| 2023 2 | 36 | 22 | 58 |
| 2023 1 | 41 | 21 | 62 |
| 2022 12 | 67 | 51 | 118 |
| 2022 11 | 63 | 37 | 100 |
| 2022 10 | 61 | 27 | 88 |
| 2022 9 | 63 | 52 | 115 |
| 2022 8 | 45 | 38 | 83 |
| 2022 7 | 45 | 38 | 83 |
| 2022 6 | 44 | 38 | 82 |
| 2022 5 | 38 | 35 | 73 |
| 2022 4 | 38 | 42 | 80 |
| 2022 3 | 34 | 39 | 73 |
| 2022 2 | 36 | 64 | 100 |
| 2022 1 | 44 | 44 | 88 |
| 2021 12 | 39 | 48 | 87 |
| 2021 11 | 41 | 43 | 84 |
| 2021 10 | 43 | 45 | 88 |
| 2021 9 | 31 | 34 | 65 |
| 2021 8 | 34 | 28 | 62 |
| 2021 7 | 26 | 39 | 65 |
| 2021 6 | 28 | 28 | 56 |
| 2021 5 | 38 | 36 | 74 |
| 2021 4 | 77 | 50 | 127 |
| 2021 3 | 3 | 3 | 6 |
| 2020 12 | 19 | 12 | 31 |
| 2020 11 | 15 | 16 | 31 |
| 2020 10 | 21 | 21 | 42 |
| 2020 9 | 13 | 22 | 35 |
| 2020 8 | 15 | 11 | 26 |
| 2020 7 | 22 | 22 | 44 |
| 2020 6 | 20 | 6 | 26 |
| 2020 5 | 26 | 13 | 39 |
| 2020 4 | 15 | 17 | 32 |
| 2020 3 | 21 | 11 | 32 |
| 2020 2 | 15 | 8 | 23 |
| 2020 1 | 17 | 15 | 32 |
| 2019 12 | 25 | 6 | 31 |
| 2019 11 | 26 | 7 | 33 |
| 2019 10 | 21 | 7 | 28 |
| 2019 9 | 29 | 11 | 40 |
| 2019 8 | 29 | 10 | 39 |
| 2019 7 | 18 | 14 | 32 |
| 2019 6 | 19 | 23 | 42 |
| 2019 5 | 24 | 29 | 53 |
| 2019 4 | 23 | 32 | 55 |
| 2019 3 | 29 | 18 | 47 |
| 2019 2 | 27 | 17 | 44 |
| 2019 1 | 29 | 33 | 62 |
| 2018 12 | 37 | 29 | 66 |
| 2018 11 | 32 | 22 | 54 |
| 2018 10 | 36 | 23 | 59 |
| 2018 9 | 23 | 38 | 61 |
| 2018 8 | 18 | 20 | 38 |
| 2018 7 | 27 | 15 | 42 |
| 2018 6 | 29 | 27 | 56 |
| 2018 5 | 26 | 34 | 60 |
| 2018 4 | 46 | 25 | 71 |
| 2018 3 | 29 | 12 | 41 |
| 2018 2 | 15 | 3 | 18 |
| 2018 1 | 30 | 6 | 36 |
| 2017 12 | 34 | 11 | 45 |
| 2017 11 | 19 | 7 | 26 |
| 2017 10 | 15 | 4 | 19 |
| 2017 9 | 14 | 12 | 26 |
| 2017 8 | 21 | 24 | 45 |
| 2017 7 | 21 | 28 | 49 |
| 2017 6 | 28 | 30 | 58 |
| 2017 5 | 39 | 33 | 72 |
| 2017 4 | 391 | 194 | 585 |
| 2017 3 | 15 | 13 | 28 |
| 2017 2 | 32 | 15 | 47 |
| 2017 1 | 25 | 11 | 36 |
| 2016 12 | 24 | 13 | 37 |
| 2016 11 | 35 | 10 | 45 |
| 2016 10 | 41 | 8 | 49 |
| 2016 9 | 27 | 14 | 41 |
| 2016 8 | 21 | 14 | 35 |
| 2016 7 | 20 | 6 | 26 |
| 2016 6 | 28 | 7 | 35 |
| 2016 5 | 37 | 17 | 54 |
| 2016 4 | 32 | 7 | 39 |
| 2016 3 | 23 | 11 | 34 |
| 2016 2 | 34 | 13 | 47 |
| 2016 1 | 34 | 10 | 44 |
| 2015 12 | 20 | 8 | 28 |
| 2015 11 | 22 | 10 | 32 |
| 2015 10 | 20 | 7 | 27 |
| 2015 9 | 32 | 13 | 45 |
| 2015 8 | 24 | 8 | 32 |
| 2015 7 | 25 | 4 | 29 |
| 2015 6 | 13 | 1 | 14 |
| 2015 5 | 19 | 6 | 25 |
| 2015 4 | 15 | 6 | 21 |
| 2015 3 | 32 | 4 | 36 |
| 2015 2 | 11 | 5 | 16 |
| 2015 1 | 11 | 5 | 16 |
| 2014 12 | 10 | 7 | 17 |
| 2014 11 | 16 | 9 | 25 |
| 2014 10 | 17 | 15 | 32 |
| 2014 9 | 8 | 30 | 38 |
| 2014 8 | 19 | 16 | 35 |
| 2014 7 | 15 | 14 | 29 |
Show all
